Regression of columnar-lines (Barrett's) oesophagus with omeprazole 40 mg daily: Results of 5 years of continuous therapy

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 9, 1999, Pages 1205-1209

  Wilkinson, S P ^a,b   Biddlestone, L ^a   Gore, S ^a   Shepherd, N A ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; ANTIULCER AGENT; ENZYME INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; DRUG EFFICACY; DYSPLASIA; EPITHELIZATION; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; DRUG ADMINISTRATION; GASTROINTESTINAL ENDOSCOPY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 0032586739     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00593.x     Document Type: Article

References (21)

1. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-6.
2. Ireland AP, Clark GWB, De Meester TR. Carcinoma of the cardia: Role of short-segment Barrett's esophagus and columnar metaplasia. Dis Esoph 1996; 9: 159-64.
3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991; 265: 1287-9.
4. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increase in frequency of adenocarcinoma of the esophagus. Cancer 1989; 64: 526-30.
5. Iftikhar SY, Janes PD, Steele RJC, et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-8.
6. Hameeteman W, Tytgat GNG, Houthoff HJ, van den Tweel JG. Barrett's esophagus. Development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-56.
7. Wright TA, Gray MR, Morris AI, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39: 574-9.
8. Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993; 7: 623-8.
9. Cooper BT, Neumann CS, Cox MA, Iqbal TH. Continuous treatment with omeprazole 20 mg daily for up to six years in Barrett's oesophagus. Aliment Pharmacol Ther 1998; 12: 893-7.
10. Sampliner RE. Effect of up to three years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89: 1844-8.
11. Biddlestone LR, Barham CP, Wilkinson SP, et al. The histopathology of treated Barren's esophagus: Squamous re-epithelialisation following acid-suppression, laser and photodynamic therapy. Amer J Surg Pathol, 1998; 22: 239-45.
12. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's oesophagus) by photodynamic therapy within endogenously generated protoporphyrin IX. Lancet 1996; 348: 584-5.
13. Jass JR. Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study. J Clin Pathol 1981; 34: 866-70.
14. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994; 89: 989-91.
15. Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 1996; 44: 700-5.
16. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997; 92: 582-5.
17. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with and suppression and multipolar electrocoagulation: Preliminary results. Gastrointest Endosc 1996; 44: 523-5.
18. Van Laethem J-L, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 1998; 43: 747-51.
19. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: Clinical update. Am J Gastroenterol 1996; 91: 1719-23.
20. Williamson WA, Ellis FH, Gibbs SP, et al. Effect of anti-reflux operation on Barrett's mucosa. Ann Thorac Surg 1990; 49: 537-41.
21. Sagar PM, Ackroyd R, Hosie KB, et al. Regression and progression of Barrett's oesophagus after anti-reflux surgery. Br J Surg 1995; 82: 806-10.